A key mechanism regulating the function of cells of the bone matrix is the molecular triad osteoprotegerin (OPG)/receptor activator of NF-kB (RANK)/RANK ligand (RANKL) pathway [10]; disturbance of this mechanism by cancer cells leads to increased osteolysis [8,11,12]. The gene discussed is TNFRSF11A; the disease is cancer.